Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124951363 | 12495136 | 3 | F | 2015 | 20160916 | 20160624 | 20160921 | EXP | PHHY2016FR030752 | NOVARTIS | 61.00 | YR | F | Y | 64.00000 | KG | 20160921 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124951363 | 12495136 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Unknown | 10 MG, QD | 22334 | 10 | MG | QD | |||||||
| 124951363 | 12495136 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 124951363 | 12495136 | 3 | C | PREVISCAN | FLUINDIONE | 1 | Oral | 0 | |||||||||||
| 124951363 | 12495136 | 4 | C | SOMATULINE LP | LANREOTIDE ACETATE | 1 | Intramuscular | 120 MG, UNK | 0 | 120 | MG | ||||||||
| 124951363 | 12495136 | 5 | C | INNOHEP | TINZAPARIN SODIUM | 1 | Subcutaneous | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124951363 | 12495136 | 1 | Pancreatic neuroendocrine tumour |
| 124951363 | 12495136 | 2 | Hypercholesterolaemia |
| 124951363 | 12495136 | 3 | Subclavian vein thrombosis |
| 124951363 | 12495136 | 4 | Pancreatic neuroendocrine tumour |
| 124951363 | 12495136 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124951363 | 12495136 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124951363 | 12495136 | Anaemia | |
| 124951363 | 12495136 | Aphthous ulcer | |
| 124951363 | 12495136 | Burning sensation mucosal | |
| 124951363 | 12495136 | Concomitant disease aggravated | |
| 124951363 | 12495136 | Ear infection | |
| 124951363 | 12495136 | Epistaxis | |
| 124951363 | 12495136 | Headache | |
| 124951363 | 12495136 | Hypercholesterolaemia | |
| 124951363 | 12495136 | Hypertriglyceridaemia | |
| 124951363 | 12495136 | Interstitial lung disease | |
| 124951363 | 12495136 | Mucosal inflammation | |
| 124951363 | 12495136 | Nasal crusting | |
| 124951363 | 12495136 | Nasal discomfort | |
| 124951363 | 12495136 | Pulmonary mass | |
| 124951363 | 12495136 | Rhinalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124951363 | 12495136 | 1 | 20150908 | 0 | ||
| 124951363 | 12495136 | 2 | 20151023 | 0 | ||
| 124951363 | 12495136 | 3 | 201512 | 0 | ||
| 124951363 | 12495136 | 4 | 20130801 | 0 | ||
| 124951363 | 12495136 | 5 | 201512 | 0 |